Recall of Valsartan and Valsartan-HCTZ by Solco Healthcare, Major and Teva
Due to the recall, Valsartan and Valsartan-HCTZ tablets may be in limited supply
This notice is provided to alert prescribers that on July 13, 2018 the FDA announced a voluntary recall of Valsartan and Valsartain-HCTZ tablets which may cause a supply limitation. Please refer to the tables in the pdf's on this page for potential alternative therapies and equivalent ARB daily dosing for Valsartan.
Valsartan Prescriber Fax Cover Letter
Valsartan ARB Equivalent